Samaneh Mohammadi
1, Javid Shahbazi Mojarrad
2, Parvin Zakeri-Milani
3, Ali Shirani
1, Samad Mussa Farkhani
1, Naser Samadi
1, Hadi Valizadeh
4*1 Faculty of Advanced Medical Sciences, Department of Medical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Research Center for Pharmaceutical Nanotechnology and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Liver and Gastrointestinal Diseases Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
4 Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Purpose: Breast cancer is the second leading cancer
type among people of advanced countries. Various methods have been used for cancer treatment such as chemotherapy
and radiotherapy. In the present study we have designed and synthesized a new group of drug
delivery systems (DDS) containing a new class of Cell Penetrating Peptides (CPPs)
named Peptide Amphiphiles (PAs).
Methods: Two PAs and anionic peptides were synthesized using solid phase peptide
synthesis (SPPS), namely [KW]4, [KW]5, E4 and E8. Then nano-peptides were
synthesized by non-covalent binding between PAs and poly anions as [KW]4-E4,
[KW]4-E8, [KW]5-E4 and [KW]5-E8.
Results: Flow
cytometry studies showed that increased chain
length of PAs with a higher ratio between hydrophobicity and net charge results
in increased intracellular uptake by MCF7 cells after 2h incubation. Moreover, nano-peptides showed greater intracellular uptake
compared to PAs. Anti-proliferative assay
revealed that by increasing chain length of PAs, the
toxicity effect on MCF7 cells is reduced, however nano-peptides did not show significant toxicity on MCF7 cells
even at high concentration levels.
Conclusion: These data
suggest that due to the lack of toxicity effect at high concentration
levels and also high cellular uptake, nano-peptides are
more suitable carrier compared to PAs for
drug delivery.